M. Hartmann et al., ALPHA-1-ADRENOCEPTOR STIMULATION INHIBITS THE ISOPROTERENOL-INDUCED EFFECTS ON MYOCARDIAL-CONTRACTILITY AND PROTEIN-PHOSPHORYLATION, European journal of pharmacology, 287(1), 1995, pp. 57-64
In the present study the influence of alpha(1)-adrenoceptor stimulatio
n on the beta-adrenoceptor agonist-induced increases in contractile pa
rameters and protein phosphorylation was determined in isolated perfus
ed hearts and isolated cardiac myocytes, respectively. Methoxamine inh
ibited the isoproterenol-induced increases in left ventricular pressur
e and heart rate dose dependently up to 90% and 75%, respectively; the
EC(50) of this antiadrenergic effect was 4.4 mu M. The alpha(1)-adren
oceptor antagonist, prazosin (1 mu M), greatly diminished methoxamine'
s inhibitory action, confirming the alpha(1)-adrenoceptor-mediated mec
hanism. The inotropic effect of glucagon was inhibited by methoxamine
in a similar manner. Radioligand binding assays with [H-3]dihydroalpre
nolol demonstrated that the antiadrenergic action of methoxamine is no
t due to an unspecific beta-adrenoceptor blocking property. In an addi
tional experimental series the effects of methoxamine and isoprotereno
l on the protein phosphorylation pattern of isolated cardiac myocytes
were investigated. Isoproterenol increased the phosphorylation state o
f five proteins (6-kDa, phospholamban; 15-kDa; 28-kDa, troponin I; 97-
kDa; 140-kDa) while in the experiments with methoxamine the 15-kDa pro
tein was the only phosphorylated substrate. In the presence of methoxa
mine the isoproterenol-induced phosphorylation of phospholamban, tropo
nin I and the 97-kDa and 140-kDa protein was markedly inhibited while
the phosphorylation state of the 15-kDa protein remained unaltered. Th
e present study clearly demonstrated that alpha(1)-adrenoceptor stimul
ation potently inhibits the beta-adrenoceptor-mediated changes in cont
ractile force and phosphorylation of key regulatory proteins, most lik
ely through modulation of cAMP metabolism